Evidence map›Paper›PMID 38160254›Full record

ArticleHGG advances2024

Olfactory receptor genes and chromosome 11 structural aberrations: Players or spectators?

Serena Redaelli, Francesca Romana Grati, Viviana Tritto, Giuliana Giannuzzi, Maria Paola Recalcati, Elena Sala, Nicoletta Villa, Francesca Crosti, Gaia Roversi, Francesca Malvestiti and 12 more

Open access · goldAbstract read
In one paragraph

Article in HGG advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 1 country.

Serena RedaelliSchool of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Francesca Romana GratiR&D, Cytogenetics, Molecular Genetics and Medical Genetics Unit, Toma Advanced Biomedical Assays S.p.A. (ImpactLab), 21052 Busto Arsizio, Italy.
Viviana TrittoDepartment of Medical Biotechnology and Translational Medicine, University of Milan, 20122 Milan, Italy.
Giuliana GiannuzziDepartment of Biosciences, University of Milan, 20122 Milan, Italy.
Maria Paola RecalcatiIRCCS Istituto Auxologico Italiano, Medical Cytogenetics Laboratory, 20095 Cusano Milanino, Italy.
Elena SalaUC Medical Genetics, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Nicoletta VillaUC Medical Genetics, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Francesca CrostiUC Medical Genetics, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Gaia RoversiSchool of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy; UC Medical Genetics, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Francesca MalvestitiR&D, Cytogenetics, Molecular Genetics and Medical Genetics Unit, Toma Advanced Biomedical Assays S.p.A. (ImpactLab), 21052 Busto Arsizio, Italy.
Valentina ZanattaR&D, Cytogenetics, Molecular Genetics and Medical Genetics Unit, Toma Advanced Biomedical Assays S.p.A. (ImpactLab), 21052 Busto Arsizio, Italy.
Elena RepettiR&D, Cytogenetics, Molecular Genetics and Medical Genetics Unit, Toma Advanced Biomedical Assays S.p.A. (ImpactLab), 21052 Busto Arsizio, Italy.
Ornella RodeschiniIRCCS Istituto Auxologico Italiano, Medical Cytogenetics Laboratory, 20095 Cusano Milanino, Italy.
Chiara ValtortaIRCCS Istituto Auxologico Italiano, Medical Cytogenetics Laboratory, 20095 Cusano Milanino, Italy.
Ilaria CatusiIRCCS Istituto Auxologico Italiano, Medical Cytogenetics Laboratory, 20095 Cusano Milanino, Italy.
Lorenza RomittiPathology and Cytogenetics Laboratory, Clinical Pathology Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20162 Milan, Italy.
Emanuela MartinoliDepartment of Medical Biotechnology and Translational Medicine, University of Milan, 20122 Milan, Italy.
Donatella ConconiSchool of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Leda DalpràSchool of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy; UC Medical Genetics, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Marialuisa LavitranoSchool of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Paola RivaDepartment of Medical Biotechnology and Translational Medicine, University of Milan, 20122 Milan, Italy.
Angela BentivegnaSchool of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy. Electronic address: angela.bentivegna@unimib.it.
Azienda Ospedaliera San Gerardo · ITIRCCS Istituto Auxologico Italiano · ITUniversity of Milan · ITUniversity of Milano-Bicocca · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The largest multi-gene family in metazoans is the family of olfactory receptor (OR) genes. Human ORs are organized in clusters over most chromosomes and seem to include >0.1% the human genome. Because 369 out of 856 OR genes are mapped on chromosome 11 (HSA11), we sought to determine whether they mediate structural rearrangements involving this chromosome. To this aim, we analyzed 220 specimens collected during diagnostic procedures involving structural rearrangements of chromosome 11. A total of 222 chromosomal abnormalities were included, consisting of inversions, deletions, translocations, duplications, and one insertion, detected by conventional chromosome analysis and/or fluorescence in situ hybridization (FISH) and array comparative genomic hybridization (array-CGH). We verified by bioinformatics and statistical approaches the occurrence of breakpoints in cytobands with or without OR genes. We found that OR genes are not involved in chromosome 11 reciprocal translocations, suggesting that different DNA motifs and mechanisms based on homology or non-homology recombination can cause chromosome 11 structural alterations. We also considered the proximity between the chromosomal territories of chromosome 11 and its partner chromosomes involved in the translocations by using the deposited Hi-C data concerning the possible occurrence of chromosome interactions. Interestingly, most of the breakpoints are located in regions highly involved in chromosome interactions. Further studies should be carried out to confirm the potential role of chromosome territories' proximity in promoting genome structural variation, so fundamental in our understanding of the molecular basis of medical genetics and evolutionary genetics.

Indexed as

Chromosomes, Human, Pair 11Receptors, OdorantChromosome AberrationsComparative Genomic HybridizationHumansIn Situ Hybridization, FluorescenceTranslocation, GeneticReceptors, Odorantchromosomal rearrangementschromosomal territorieschromosome 11cytogeneticscytogenomicsMMBIRNAHRNHEJnon-allelic homologous recombinationnon-homologous end joiningolfactory receptor genesreplication-based microhomology-mediated break-induced replicationstructural chromosomal aberrationsstructural variants

Identifiers

PMID38160254
PMCPMC10820794
OpenAlexW4390452828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.